Contents

Current Pharmaceutical Design, Volume 15 - Number 29

Simultaneous Optimization of Potency, Selectivity and Physicochemical Properties for Cannabinoid CB2 Ligands

, 15(29): 3345 - 3366

Karin Worm and Roland E. Dolle


DOI: 10.2174/138161209789105027




Pathophysiological Insights into Atrial Fibrillation Following Cardiac Surgery: Implications for Current Pharmaceutical Design

, 15(29): 3367 - 3383

D. Kaireviciute, A. Aidietis and G. Y.H. Lip


DOI: 10.2174/138161209789105063




Developing Novel Therapeutic Approaches to Frailty

, 15(29): 3384 - 3395

John E. Morley


DOI: 10.2174/138161209789105045




Role of Chemokines and Their Receptors in Cancer

, 15(29): 3396 - 3416

Roeliene C. Kruizinga, Jovanka Bestebroer, Paul Berghuis, Carla J.C. de Haas, Thera P. Links, Elisabeth G.E. de Vries and Annemiek M.E. Walenkamp


DOI: 10.2174/138161209789105081




Vascular Damage in Impaired Glucose Tolerance: An Unappreciated Phenomenon?

, 15(29): 3417 - 3432

Shahirose Jessani, Teri Millane and Gregory Y.H. Lip


DOI: 10.2174/138161209789105072




Mast Cells: Target and Source of Neuropeptides

, 15(29): 3433 - 3445

F. Tore and N. Tuncel


DOI: 10.2174/138161209789105036




Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

, 15(29): 3446 - 3462

M. Florentin, M. S. Elisaf, D. P. Mikhailidis and E. N. Liberopoulos


DOI: 10.2174/138161209789105054




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science